In The News

If President Joe Biden’s last big science project was a moonshot, his new one has goals that are light years further. The proposed Advanced Research Projects Agency would deliver breakthrough…

Vaccines are critical to curbing the ongoing COVID-19 pandemic, but cancer patients have largely been left out of clinical trials testing the efficacy of such treatments.  That must change, the…

An accelerated approval program for U.S. drugs that’s been around for almost three decades is under fire for the criteria used by regulators to decide which therapies should be greenlighted, and for…

AITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced the…

All cancer patients or those with a history of cancer should be eligible for COVID-19 vaccine trials and other clinical trials, unless there is credible risk of harm from participation, the American…

The controversial approval of the Alzheimer's disease medicine aducanumab has drawn new attention to the Biden administration's delay in nominating a candidate to be the top US drug regulator. To…

People with cancer should be included in COVID-19 vaccine clinical trials, according to a new joint position statement from the American Society of Clinical Oncology (ASCO) and the Friends of Cancer…

New ASCO-Friends Joint Position Statement Encourages Enrollment of Patients with Cancer in Vaccine Studies Alexandria, Va. and Washington, DC. – Individuals with cancer or a history of cancer should…

Friends of Cancer Research has launched Step 2 of the ctDNA for Monitoring Treatment Response (ctMoniTR) Project.  This project aims to determine the extent to which changes in circulating tumor DNA…

The Friends of Cancer Research (FCR) has launched the next stage of a project that studies whether circulating tumor DNA changes can be used to track early response to cancer therapies.   The launch…